已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Prevalence, risk factors, and management of asthma in China: a national cross-sectional study

哮喘 医学 中国 横断面研究 环境卫生 哮喘管理 地理 内科学 病理 考古
作者
Kewu Huang,Ting Yang,Jianying Xu,Lan Yang,Jianping Zhao,Xiangyan Zhang,Chunxue Bai,Jian Kang,Pixin Ran,Huahao Shen,Fuqiang Wen,Yahong Chen,Tieying Sun,Guangliang Shan,Yingxiang Lin,Guodong Xu,Sinan Wu,Chaolong Wang,Ruiying Wang,Zhihong Shi,Yongjian Xu,Xianwei Ye,Yuanlin Song,Qiuyue Wang,Yumin Zhou,Wen Li,Liren Ding,Chun Wan,Wan-zhen Yao,Yanfei Guo,Fei Xiao,Yong Lü,Xiaoxia Peng,Biao Zhang,Dan Xiao,Zuomin Wang,Zhengming Chen,Xiaoning Bu,Hong Zhang,Xiaolei Zhang,Li An,Shu Zhang,Jian-Guo Zhu,Zhixin Cao,Qingyuan Zhan,Yuanhua Yang,Lirong Liang,Xunliang Tong,Huaping Dai,Bin Cao,Zhenhua Wu,Kian Fan Chung,Jiang He,Chen Wang
出处
期刊:The Lancet [Elsevier]
卷期号:394 (10196): 407-418 被引量:493
标识
DOI:10.1016/s0140-6736(19)31147-x
摘要

Asthma is a common chronic airway disease worldwide. Despite its large population size, China has had no comprehensive study of the national prevalence, risk factors, and management of asthma. We therefore aimed to estimate the national prevalence of asthma in a representative sample of the Chinese population.A representative sample of 57 779 adults aged 20 years or older was recruited for the national cross-sectional China Pulmonary Health (CPH) study using a multi-stage stratified sampling method with parameters derived from the 2010 census. Ten Chinese provinces, representative of all socioeconomic settings, from six geographical regions were selected, and all assessments were done in local health centres. Exclusion criteria were temporary residence, inability to take a spirometry test, hospital treatment of cardiovascular conditions or tuberculosis, and pregnancy and breastfeeding. Asthma was determined on the basis of a self-reported history of diagnosis by a physician or by wheezing symptoms in the preceding 12 months. All participants were assessed with a standard asthma questionnaire and were classed as having or not having airflow limitation through pulmonary function tests before and after the use of a bronchodilator (400 μg of salbutamol). Risk factors for asthma were examined by multivariable-adjusted analyses done in all participants for whom data on the variables of interest were available. Disease management was assessed by the self-reported history of physician diagnosis, treatments, and hospital visits in people with asthma.Between June 22, 2012, and May 25, 2015, 57 779 participants were recruited into the CPH study. 50 991 (21 446 men and 29 545 women) completed the questionnaire survey and had reliable post-bronchodilator pulmonary function test results and were thus included in the final analysis. The overall prevalence of asthma in our sample was 4·2% (95% CI 3·1-5·6), representing 45·7 million Chinese adults. The prevalence of asthma with airflow limitation was 1·1% (0·9-1·4), representing 13·1 million adults. Cigarette smoking (odds ratio [OR] 1·89, 95% CI 1·26-2·84; p=0·004), allergic rhinitis (3·06, 2·26-4·15; p<0·0001), childhood pneumonia or bronchitis (2·43, 1·44-4·10; p=0·002), parental history of respiratory disease (1·44, 1·02-2·04; p=0·040), and low education attainment (p=0·045) were associated with prevalent asthma. In 2032 people with asthma, only 28·8% (95% CI 19·7-40·0) reported ever being diagnosed by a physician, 23·4% (13·9-36·6) had a previous pulmonary function test, and 5·6% (3·1-9·9) had been treated with inhaled corticosteroids. Furthermore, 15·5% (11·4-20·8) people with asthma reported at least one emergency room visit and 7·2% (4·9-10·5) at least one hospital admission due to exacerbation of respiratory symptoms within the preceding year.Asthma is prevalent but largely undiagnosed and undertreated in China. It is crucial to increase the awareness of asthma and disseminate standardised treatment in clinical settings to reduce the disease burden.National Key R&D Program of China, Ministry of Science and Technology of China; the Special Research Foundation for Public Welfare of Health, Ministry of Health of China; the Chinese National Research Program for Key Issues in Air Pollution Control; and the National Natural Science Foundation of China.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
汉堡包应助guzhiwen采纳,获得10
刚刚
2秒前
Owen应助mochi采纳,获得10
4秒前
zdy完成签到,获得积分10
6秒前
ASHSR完成签到 ,获得积分10
6秒前
Winner完成签到,获得积分10
7秒前
JY应助快乐滑板采纳,获得10
8秒前
8秒前
所所应助细心怜寒采纳,获得10
9秒前
曲悦完成签到,获得积分10
10秒前
Brain完成签到,获得积分10
11秒前
酷波er应助薛定谔的猫采纳,获得10
12秒前
WUHUIWEN完成签到,获得积分10
13秒前
guzhiwen发布了新的文献求助10
13秒前
15秒前
醉倒天瓢完成签到 ,获得积分10
15秒前
16秒前
梵星完成签到 ,获得积分10
16秒前
16秒前
啊强完成签到 ,获得积分10
17秒前
岳小龙完成签到 ,获得积分10
17秒前
孤独梦安发布了新的文献求助10
17秒前
Zxc完成签到,获得积分10
17秒前
19秒前
Ava应助haoooooooooooooo采纳,获得10
21秒前
Leofar完成签到 ,获得积分10
21秒前
韩冬冬发布了新的文献求助10
22秒前
mochi完成签到,获得积分10
22秒前
23秒前
喵喵发布了新的文献求助10
28秒前
29秒前
30秒前
吾日三省吾身完成签到 ,获得积分10
33秒前
Zxc发布了新的文献求助10
36秒前
冷傲的道罡完成签到,获得积分10
48秒前
天天快乐应助xuan采纳,获得10
49秒前
guzhiwen完成签到,获得积分10
50秒前
希望天下0贩的0应助OA采纳,获得30
53秒前
58秒前
Owen应助小龟别乱跑采纳,获得10
1分钟前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
XAFS for Everyone (2nd Edition) 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3133855
求助须知:如何正确求助?哪些是违规求助? 2784787
关于积分的说明 7768474
捐赠科研通 2440139
什么是DOI,文献DOI怎么找? 1297185
科研通“疑难数据库(出版商)”最低求助积分说明 624901
版权声明 600791